Is the Orocobre Limited (ASX:ORE) share price in the buy zone after today's update?

The Orocobre Limited (ASX:ORE) share price has pushed higher today after the release of an update. Is the lithium miner in the buy zone?

| More on:
a woman

You’re reading a free article with opinions that may differ from The Motley Fool’s Premium Investing Services. Become a Motley Fool member today to get instant access to our top analyst recommendations, in-depth research, investing resources, and more. Learn More

The Australian share market certainly is having a day to forget on Tuesday. In afternoon trade the benchmark ASX 200 is down a sizeable 1.7% with almost all sectors dropping lower.

The same cannot be said for the Orocobre Limited (ASX: ORE) share price, though. At the time of writing the lithium miner's shares have defied the market selloff and pushed 3.5% higher to $4.70.

This is despite industry peers Galaxy Resources Limited (ASX: GXY), Kidman Resources Ltd (ASX: KDR), and Pilbara Minerals Ltd (ASX: PLS) all falling heavily today.

Why are Orocobre's shares storming higher?

This morning Orocobre released an investor presentation and the market appears to have liked what it saw.

As well as providing an update on its operations and the improvements it has experienced with pricing and costs, management provided an update on the lithium market.

One thing of note that management pointed out in the presentation was how inaccurate long-term supply forecasts have been in the past. As you can see below, 2017's supply fell well short of predictions.

Source: ORE

Management has put this down to increased royalties and taxes in Chile, the under-delivery of conversion plan capacity expansions and brownfield brine expansions, and new hard rock supply at lower than expected grades.

The good news for Orocobre shareholders is that management appears confident that the lithium market will remain tight in the future and support high prices of the battery making ingredient.

Source: ORE

On the above chart, the green dotted line represents its optimistic demand forecast, whereas the red line represents the base demand forecast, and the black line represents the pessimistic demand forecast.

The base case is for demand to grow by 22% per annum between 2017 and 2022. This is expected to be driven by increasing electric vehicle (EV) adoption and implies EV penetration of 4.4% by 2020.

The pessimistic forecast implies 17% growth in demand per annum during the period and EV penetration of 3.5%. Finally, the optimistic forecast is for demand growth of 26% per annum and EV penetration of 5.4%.

And in respect to supply, Orocobre expects persisting bottlenecks, slower ramp-ups, and higher costs to limit supply growth and lead to continued tight market conditions.

Whether or not this forecast proves accurate, only time will tell. But if it is correct and demand grows at the base level, I expect Orocobre and its peers to benefit from favourable lithium prices for many years to come.

This could make them worth considering, but only if you have a high tolerance for risk and can stomach the high levels of volatility that their shares exhibit.

Should you invest $1,000 in Ampol Limited right now?

Before you buy Ampol Limited shares, consider this:

Motley Fool investing expert Scott Phillips just revealed what he believes are the 5 best stocks for investors to buy right now... and Ampol Limited wasn't one of them.

The online investing service he’s run for over a decade, Motley Fool Share Advisor, has provided thousands of paying members with stock picks that have doubled, tripled or even more.*

And right now, Scott thinks there are 5 stocks that may be better buys...

See The 5 Stocks *Returns as of 6 March 2025

Motley Fool contributor James Mickleboro owns shares of Galaxy Resources Limited. The Motley Fool Australia has no position in any of the stocks mentioned. We Fools may not all hold the same opinions, but we all believe that considering a diverse range of insights makes us better investors. The Motley Fool has a disclosure policy. This article contains general investment advice only (under AFSL 400691). Authorised by Scott Phillips.

More on Share Gainers

Silhouettes of nine people climbing a steep mountain to the top at sunset, and helping each other along the way.
Share Gainers

Here are the top 10 ASX 200 shares today

The ASX was rocked by 'Liberation Day' this Thursday.

Read more »

Child drinking milk out of a glass.
Share Gainers

Guess which ASX All Ords share just rocketed 12% in today's crashing market?

This ASX All Ords share is surging today despite the Trump tariff market turmoil. But why?

Read more »

Excited couple celebrating success while looking at smartphone.
Share Gainers

Why Astral, Newmont, Ramelius, and Synlait shares are defying the market selloff and rising

These shares are rising despite the market weakness today. But why?

Read more »

Ten happy friends leaping in the air outdoors.
Share Gainers

Here are the top 10 ASX 200 shares today

It was another positive day for ASX investors this hump day.

Read more »

Man with rocket wings which have flames coming out of them.
Share Gainers

Guess which ASX All Ords stock just rocketed 14% on BIG leadership news

Investors just sent this ASX All Ords stock surging by 14%. But why?

Read more »

Man drawing an upward line on a bar graph symbolising a rising share price.
Share Gainers

Why AMA, Emerald Resources, Kelsian, and Life360 shares are zooming higher

These shares are having a good session on hump day. But why?

Read more »

a man holds a firework sparkler in both hands as a shower of sparkly confetti falls from the sky around him as he smiles and closes his eyes in a celebratory scene.
Share Gainers

These were the best ASX 200 shares to own in Q1 of 2025

These shares made their shareholders smile over the past three months.

Read more »

A man with a wide, eager smile on his face holds up three fingers.
Healthcare Shares

3 reasons to buy this surging ASX All Ords healthcare share today

A top expert forecasts more outperformance from this rocketing ASX healthcare stock.

Read more »